What's Happening Archives - Page 6 of 10 - Sanford Burnham Prebys
Institute News

SBP spin-out company micro-gRx receives $200,000 Space Florida award

Authorpbartosch
Date

July 20, 2015

We’re excited to announce that the first funded company established based on work emerging from our Lake Nona campus, micro-gRx Incorporated, has received a $200,000 award from Space Florida through the Florida – Israel Innovation Partnership Program. micro-gRx is partnering with R&D company SpacePharma to develop a “lab on a chip” research model that enables scientists to study live human cells in microgravity. Continue reading “SBP spin-out company micro-gRx receives $200,000 Space Florida award”

Institute News

Run Noah run

Authorsgammon
Date

July 1, 2015

On Saturday, July 4, at 3 p.m., an extraordinary man named Noah Coughlan will complete a run—a solo run— that stretched more than 3,000 miles and 13 states. His journey will have lasted 127 days. Even more impressive is that this is the third time he has done it. Why on earth would someone take on such a feat? Continue reading “Run Noah run”

Institute News

2015 Sanford-Burnham faculty retreat

Authorsgammon
Date

June 5, 2015

The annual Sanford-Burnham faculty retreat was held in beautiful Carlsbad, Calif., May 19-20. Attended by more than 70 faculty from La Jolla, Calif., and Lake Nona, Fla., the retreat was an opportunity for attendees to learn more about each other’s research, share ideas, and to engage in strategic discussions related to the Institute’s 10-year vision to become a preeminent medical research institute that combines cutting-edge fundamental research with robust drug discovery. Continue reading “2015 Sanford-Burnham faculty retreat”

Institute News

New collaboration strives to find novel treatment approaches for cardiovascular disease

Authorpbartosch
Date

May 28, 2015

Sanford-Burnham today announced it has signed a two-year partnership agreement with Takeda Pharmaceutical Company Ltd. of Japan to study the potential role of several gene regulatory proteins as targets for the treatment of heart failure. Based on research conducted in Sanford-Burnham laboratories, the collaborating scientists will screen and develop molecules that have the potential to improve the metabolism and function of the failing heart. Continue reading “New collaboration strives to find novel treatment approaches for cardiovascular disease”

Institute News

Q&A with MS patient advocate Denise Boucher

Authorrbruni
Date

May 21, 2015

Denise Boucher is a vibrant, gregarious, and engaging individual, with an easy smile and a quick wit. When you meet her the for the first time and feel her infectious energy, it’s hard to imagine that she has endured a nearly 20-year long battle with multiple sclerosis (MS) that has taken most of her sight and her ability walk.

Despite these challenges, Denise does not let MS stop her from living life on her terms. She is an active, passionate MS advocate who spends her time educating others about the degenerative disease and supporting fellow survivors.

On March 24, Denise visited the Institute’s La Jolla campus for the very first time as part of the National Multiple Sclerosis Society’s (NMSS) MS Awareness Month to learn more about how our researchers are making advancements in the fight against this immune-mediated disease.

We sat down with her after her visit to hear some highlights from her time at the Institute.

Q: Tell us a little about yourself and how you became a research advocate for MS?

A: When I was 25, I moved to Arizona to continue my dream career in advertising. Suddenly, strange things began to happen, including numbness on one side of my body and later blindness in one eye.

My eyesight, which I’d never had any problems with before, was becoming an increasing issue. I later learned that this is a common early symptom for MS patients. It progressed very quickly from there and it wasn’t long before my doctors diagnosed me with MS. Shortly after, I lost most of the vision in my other eye.

It’s hard to explain what a diagnosis like that means to you when you’re 25, but I tried to keep moving forward with my life and not let it derail my career, or impact my ability stay positive and enjoy my life. After a while, my symptoms progressed and I knew that things had to change. I managed to continue working in advertising for many years, but after 21 years I ended my career to focus on my health.

It was a very difficult time, to say the least, but I made the best of it. I became an advocate along the way to help others in a similar situation and share what I’ve learned with them. It’s my way to give back, stay active, positive, and move forward with my life.

Q. When you hear about research happening at Sanford-Burnham, what does it mean to you?

A. When I was first invited to join the MS tour I was so, so excited. This was really an opportunity of a lifetime, in my opinion, to visit with scientists and learn more about what they do and the impact that they could have on potential treatments.

Just being at Sanford-Burnham and seeing what’s going on lets me know that the future will be easier for others. Seeing the dedicated scientists at Sanford-Burnham and hearing their passion for curing this disease, fills me with hope. And that means a lot.

Q. What were some of your takeaways from your visit to the Institute?

This visit meant more than I ever expected. Truthfully. You read and hear about research, but you rarely have the opportunity connect what scientists are doing to the potential end result. When you’re here on campus, talking to the scientists—who are so passionate about their work—it becomes much clearer how their research is directly correlated to future medicines.

I was also blown away by how collaborative the Institute is. I had no idea how many different departments work together with so many different specialties in order to make the discoveries that they do. The whole visit was incredibly enlightening.

Q. Why do you support early-stage research, like Dr. Ranscht’s? Dr. Ranscht is an incredible woman and her passion for curing MS is palpable. She cares and is dedicating her life to finding innovative new approaches to tackling this disease. How could I not support that?

Without people and research like hers, the next big discovery won’t be found and next-generation medicines can’t be developed. Early-stage research is imperative to our future.

 

If you would like to arrange a visit to the Institute to learn more about our research, please contact Sandy Hanna at Shanna@sanfordburnham.org, or call 858-795-5056.

Institute News

Lilly and Sanford-Burnham announce collaboration to investigate immunological therapies

Authorpbartosch
Date

May 14, 2015

Today, Eli Lilly and Sanford-Burnham announced a novel collaboration to discover and develop immunological therapies. The two organizations will investigate potential therapeutics using biotechnology approaches in targeting multiple immune checkpoint modulators for the treatment of immunological diseases such as lupus, Sjögren’s syndrome, inflammatory bowel disease, and other autoimmune disorders. Continue reading “Lilly and Sanford-Burnham announce collaboration to investigate immunological therapies”

Institute News

LEAD San Diego visits Sanford-Burnham in La Jolla

Authorrbruni
Date

May 13, 2015

On Tuesday, May 5, Sanford-Burnham hosted LEAD San Diego, a local civic leadership organization that helps emerging and seasoned leaders in all sectors of the San Diego community expand their skills and enhance their knowledge of the local business enterprises, for a special breakfast and tour.

The visitors enjoyed a welcome by Institute CEO Dr. Perry Nisen before embarking on a tour of the state-of-the-art La Jolla, Calif., facilities.

Tour highlights included a stop at the Conrad Prebys Center for Chemical Genomics, where Dr. Anne Bang, Director, Cell Biology, gave a brief overview on  how the Institute utilizes cutting-edge technology to identify the precise small molecules that will become the building blocks of future medicines.

The visitors also had the opportunity to stop by the Center for Stem Cell Biology and Regeneration, where Dr. Yang Liu, a visiting researcher in the lab of Dr. Evan Synder, Professor, Human Genetics Program, gave them an overview of the Institute’s stem cell studies.

If you would like to arrange a visit to the Institute, please email Sandy Hanna at shanna@sanfordburnham.org or call (858)795-5056.

Dr. Yang Liu shares information on the Stem Cell Core with LEAD San Diego tour members.

Dr. Anne Bang with the LEAD San Diego group.LEAD San Diego Tour

Institute News

Sanford-Burnham at Lake Nona receives Bankhead-Coley grant to expand genomics capabilities

Authorpbartosch
Date

May 6, 2015

The Florida Department of Health recently announced the awardees of this year’s Bankhead-Coley Cancer Research Program grants. Among them is Sanford-Burnham at Lake Nona associate professor and scientific director of Analytical Genomics and Bioinformatics Ranjan Perera, PhD The three-year grant to Perera is valued at almost $1.3 million. Continue reading “Sanford-Burnham at Lake Nona receives Bankhead-Coley grant to expand genomics capabilities”

Institute News

Join us for the third annual cancer center open house – June 11

Authorrbruni
Date

April 30, 2015

Sanford-Burnham’s NCI-designated Cancer Center and the Cancer Center’s Community Advisory Board will host the third annual Cancer Center open house for cancer survivors, their families and friends, and research advocates on June 11 at 4:30 p.m. in La Jolla, Calif. The open house, titled “The Science Behind Immunotherapy,” will focus on revealing the latest discoveries and breakthroughs from our cancer center’s laboratories on harnessing the body’s own immune system to treat cancer. Continue reading “Join us for the third annual cancer center open house – June 11”

Institute News

Welcome to the new Beaker!

Authorpbartosch
Date

April 29, 2015

In March, we celebrated the fifth anniversary of the launch of Sanford-Burnham’s science blog Beaker. Today, we are thrilled to announce that we have completely redesigned our blog to make it more intuitive, visually appealing, and interactive. We’ll get into the features of the new Beaker further down, but first, let’s travel back in time…

It all started at 11:34 a.m. Eastern Time on March 24, 2010, with a post about T. Denny Sanford’s landmark gift of $50 million to the Institute. As a result of the gift, we changed our name from the Burnham Institute for Medical Research to Sanford-Burnham Medical Research Institute. This story kicked off Beaker, which now consists of almost 800 posts and has been visited by more than 2 million people since 2010.

A lot has happened at Sanford-Burnham since March 2010. Our scientists have made numerous significant discoveries, they’ve published hundreds of scientific papers, and we recently introduced our new Institute CEO and 10-year strategic vision. Beaker is your source for exciting news and scientific advances at Sanford-Burnham.


New Beaker Features

Our goal has been to make the reading experience unique and easy for all fans of scientific research. Here are a few of the new features:

  • Dashboard homepage: The new Beaker homepage is much more visually appealing, with a focus on images and themes. The new blog design was also chosen because it works nicely on mobile devices and tablets.
  • Categories: You can now find all stories in one of our new categories:
    • Research News – stories about our scientific publications
    • Improving Human Health – stories about disease research that has a tangible impact on health
    • What’s Happening – posts about events, industry trends, partnerships, grants, etc.
    • People – profiles and interviews with Sanford-Burnham scientists, leadership, and staff
  • Integration with social media: You can now read our live Twitter feed in the right panel of the Beaker homepage. And our Facebook integration makes it easy to leave comments and track discussion threads on our blog posts. Try it now!

We hope you are as excited about the new Beaker as we are. Let us know what you think by commenting on Facebook and Twitter, using the hashtag #TheNewBeaker.